BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27234440)

  • 1. Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.
    Maruyama S; Nakamura K; Papanicolaou KN; Sano S; Shimizu I; Asaumi Y; van den Hoff MJ; Ouchi N; Recchia FA; Walsh K
    EMBO Mol Med; 2016 Aug; 8(8):949-66. PubMed ID: 27234440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.
    Shen H; Cui G; Li Y; Ye W; Sun Y; Zhang Z; Li J; Xu G; Zeng X; Zhang Y; Zhang W; Huang Z; Chen W; Shen Z
    Stem Cell Res Ther; 2019 Jan; 10(1):17. PubMed ID: 30635025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of MicroRNA-9-5p Protects Against Cardiac Remodeling Following Myocardial Infarction in Mice.
    Xiao Y; Zhang Y; Chen Y; Li J; Zhang Z; Sun Y; Shen H; Zhao Z; Huang Z; Zhang W; Chen W; Shen Z
    Hum Gene Ther; 2019 Mar; 30(3):286-301. PubMed ID: 30101604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FSTL1 as a Potential Mediator of Exercise-Induced Cardioprotection in Post-Myocardial Infarction Rats.
    Xi Y; Gong DW; Tian Z
    Sci Rep; 2016 Aug; 6():32424. PubMed ID: 27561749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic resistance exercise increases skeletal muscle-derived FSTL1 inducing cardiac angiogenesis via DIP2A-Smad2/3 in rats following myocardial infarction.
    Xi Y; Hao M; Liang Q; Li Y; Gong DW; Tian Z
    J Sport Health Sci; 2021 Sep; 10(5):594-603. PubMed ID: 33246164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload.
    Shimano M; Ouchi N; Nakamura K; van Wijk B; Ohashi K; Asaumi Y; Higuchi A; Pimentel DR; Sam F; Murohara T; van den Hoff MJ; Walsh K
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):E899-906. PubMed ID: 21987816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.
    Hayakawa S; Ohashi K; Shibata R; Kataoka Y; Miyabe M; Enomoto T; Joki Y; Shimizu Y; Kambara T; Uemura Y; Yuasa D; Ogawa H; Matsuo K; Hiramatsu-Ito M; van den Hoff MJ; Walsh K; Murohara T; Ouchi N
    J Am Soc Nephrol; 2015 Mar; 26(3):636-46. PubMed ID: 25071081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome.
    Widera C; Giannitsis E; Kempf T; Korf-Klingebiel M; Fiedler B; Sharma S; Katus HA; Asaumi Y; Shimano M; Walsh K; Wollert KC
    Clin Chem; 2012 Aug; 58(8):1233-41. PubMed ID: 22675198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Myocardial Production of Follistatin-like 1 Is Associated With Left Ventricular Adverse Remodeling in Patients With Myocardial Infarction: Myocardial production of FSTL1 in AMI patients.
    Uematsu M; Nakamura K; Nakamura T; Watanabe Y; Yoshizaki T; Deyama J; Kobayashi T; Fujioka D; Saito Y; Kawabata K; Obata JE; Kugiyama K
    J Card Fail; 2020 Aug; 26(8):733-738. PubMed ID: 32470377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models.
    Ogura Y; Ouchi N; Ohashi K; Shibata R; Kataoka Y; Kambara T; Kito T; Maruyama S; Yuasa D; Matsuo K; Enomoto T; Uemura Y; Miyabe M; Ishii M; Yamamoto T; Shimizu Y; Walsh K; Murohara T
    Circulation; 2012 Oct; 126(14):1728-38. PubMed ID: 22929303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart.
    Oshima Y; Ouchi N; Sato K; Izumiya Y; Pimentel DR; Walsh K
    Circulation; 2008 Jun; 117(24):3099-108. PubMed ID: 18519848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follistatin-Like-1 (FSTL1) Is a Fibroblast-Derived Growth Factor That Contributes to Progression of Chronic Kidney Disease.
    Maksimowski NA; Song X; Bae EH; Reich H; John R; Pei Y; Scholey JW; Nephrotic Syndrome Study Network Neptune
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FSTL1-USP10-Notch1 Signaling Axis Protects Against Cardiac Dysfunction Through Inhibition of Myocardial Fibrosis in Diabetic Mice.
    Lu L; Ma J; Liu Y; Shao Y; Xiong X; Duan W; Gao E; Yang Q; Chen S; Yang J; Ren J; Zheng Q; Liu J
    Front Cell Dev Biol; 2021; 9():757068. PubMed ID: 34957094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction.
    Tillmanns J; Hoffmann D; Habbaba Y; Schmitto JD; Sedding D; Fraccarollo D; Galuppo P; Bauersachs J
    J Mol Cell Cardiol; 2015 Oct; 87():194-203. PubMed ID: 26319660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Dong Y; Geng Y; Li L; Li X; Yan X; Fang Y; Li X; Dong S; Liu X; Li X; Yang X; Zheng X; Xie T; Liang J; Dai H; Liu X; Yin Z; Noble PW; Jiang D; Ning W
    J Exp Med; 2015 Feb; 212(2):235-52. PubMed ID: 25584011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicardial FSTL1 reconstitution regenerates the adult mammalian heart.
    Wei K; Serpooshan V; Hurtado C; Diez-Cuñado M; Zhao M; Maruyama S; Zhu W; Fajardo G; Noseda M; Nakamura K; Tian X; Liu Q; Wang A; Matsuura Y; Bushway P; Cai W; Savchenko A; Mahmoudi M; Schneider MD; van den Hoff MJ; Butte MJ; Yang PC; Walsh K; Zhou B; Bernstein D; Mercola M; Ruiz-Lozano P
    Nature; 2015 Sep; 525(7570):479-85. PubMed ID: 26375005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follistatin-like 1: A dual regulator that promotes cardiomyocyte proliferation and fibrosis.
    Hu S; Liu H; Hu Z; Li L; Yang Y
    J Cell Physiol; 2020 Sep; 235(9):5893-5902. PubMed ID: 32017077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis.
    Fang D; Shi X; Jia X; Yang C; Wang L; Du B; Lu T; Shan L; Gao Y
    Mol Metab; 2022 Jan; 55():101400. PubMed ID: 34813964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiocrine FSTL1 (Follistatin-Like Protein 1) Insufficiency Leads to Atrial and Venous Wall Fibrosis via SMAD3 Activation.
    Jiang H; Zhang L; Liu X; Sun W; Kato K; Chen C; Li X; Li T; Sun Z; Han W; Zhang F; Xiao Q; Yang Z; Hu J; Qin Z; Adams RH; Gao X; He Y
    Arterioscler Thromb Vasc Biol; 2020 Apr; 40(4):958-972. PubMed ID: 32078339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follistatin-like 1 protects cardiomyoblasts from injury induced by sodium nitroprusside through modulating Akt and Smad1/5/9 signaling.
    Chen W; Xia J; Hu P; Zhou F; Chen Y; Wu J; Lei W; Shen Z
    Biochem Biophys Res Commun; 2016 Jan; 469(3):418-23. PubMed ID: 26687945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.